Anand Rathi is bullish on Pfizer India has recommended buy rating on the stock with a target price of Rs 4800 in its research report dated February 10, 2023. Anand Rathi is bullish on Pfizer India ...

Pfizer India posts ₹127.6 crore net profit in Q3 FY25; that’s 1.9% of ₹130 crore in the same period last year. Revenue from operations decline marginally by 0.4% YoY at ₹538 crore, ...

Aijaz Tobaccowalla, Managing Director, Pfizer India and Wyeth India. In 2009, Pfizer Inc bought rival Wyeth, but both companies left their Indian units with separate stock market listings.